Human Investing’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$502K Buy
743
+72
+11% +$42.8K 0.06% 69
2026
Q2
$336K Buy
671
+9
+1% +$4.32K 0.04% 77
2026
Q1
$325K Buy
662
+2
+0.3% +$1.08K 0.05% 75
2025
Q4
$383K Buy
+660
New +$373K 0.05% 70
2025
Q3
– Sell
-652
Closed -$264K – 97
2025
Q2
$264K Sell
652
-7
-1% -$2.93K 0.04% 81
2025
Q1
$328K Hold
659
– – 0.06% 70
2024
Q4
$343K Sell
659
-1
-0.2% -$550 0.06% 71
2024
Q3
$408K Buy
660
+7
+1% +$4.14K 0.07% 67
2024
Q2
$361K Sell
653
-1
-0.2% -$573 0.07% 67
2024
Q1
$380K Sell
654
-50
-7% -$28.1K 0.08% 68
2023
Q4
$374K Hold
704
– – 0.08% 70
2023
Q3
$356K Buy
+704
New +$375K 0.08% 74
2020
Q4
– Sell
-77
Closed -$34K – 331
2020
Q3
$34K Buy
+77
New +$31.8K 0.01% 177
2019
Q1
– Sell
-19
Closed -$4K – 416
2018
Q4
$4K Buy
+19
New +$4.46K ﹤0.01% 321

Other funds holding TMO

Human Investing's TMO Position: Q3 2026 in Review

Human Investing increased its Thermo Fisher Scientific (TMO) stake by 11% in Q3 2026, buying an estimated $42.8K and bringing the position to 743 shares worth $502K. The position accounts for 0.06% of the portfolio, ranked #69.

Human Investing first reported a position in TMO in Q4 2018 and has held it in 14 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Human Investing held 743 shares of Thermo Fisher Scientific worth $502K as of Q3 2026.
  • Human Investing bought 72 Thermo Fisher Scientific shares in Q3 2026, an estimated $42.8K.
  • Thermo Fisher Scientific made up 0.06% of Human Investing's portfolio in Q3 2026, its #69 holding.
  • Human Investing first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 14 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Human Investing's 13F filing for Q3 2026, filed 19 Oct 2026.